Literature DB >> 17638309

Bladder diary measurements in asymptomatic males: frequency, volume per void, and 24-hr volume.

William Tissot1, Cindy L Amundsen, Ananias C Diokno, George D Webster, Alfred C Coats.   

Abstract

AIMS: To collect bladder diary frequency and volume measurements from asymptomatic males and to use these data to develop clinical reference values.
MATERIALS AND METHODS: Computer processed three-day bladder diaries were collected from 92 males (median age: 46.2 years; range: 20.6-84.6 years) defined as "asymptomatic" by questionnaire. Minimum (V(min)), maximum (V(max)), and average (V(avg)) volume per void (Vol/Void), 24-hr frequency (F(24)), and 24-hr volume (V(24)) were studied. Relationships of Vol/Void and F(24) to age and V(24) and of V(24) to age were investigated by regression analysis.
RESULTS: V(max) and V(avg) increased as V(24) increased and decreased with increasing age (P < 0.0005). We found no significant relationship between V(min) and age, but V(min) increased with increasing V(24) (P < 0.0005). F(24) increased with increasing V(24) and increasing age (P < 0.0005). We found a concave downward, curvilinear relationship between age and V(24), which, while it did not reach statistical significance, was very similar in shape to age versus V(24) relationships found by other studies of larger datasets.
CONCLUSIONS: Our results suggest that reference values of F(24) and Vol/Void should be adjusted for their relationships to the patient's age and V(24). Regression equations expressing these relationships can be used to make these adjustments. From frequency histograms of residuals the difference between the patient's actual and expected reference measurement can be ranked within the reference population as a percentile. We illustrate this method by using our results to calculate age- and V(24)-adjusted 5% "normal limit" tables of F(24), V(avg), and V(max). (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 17638309     DOI: 10.1002/nau.20464

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  4 in total

1.  Randomized controlled trial of cyclic and continuous therapy with trospium and solifenacin combination for severe overactive bladder in elderly patients with regard to patient compliance.

Authors:  Kirill V Kosilov; Sergay A Loparev; Marina A Ivanovskaya; Liliya V Kosilova
Journal:  Ther Adv Urol       Date:  2014-12

2.  Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout.

Authors:  Daniel Hill-McManus; Elena Soto; Scott Marshall; Steven Lane; Dyfrig Hughes
Journal:  Br J Clin Pharmacol       Date:  2017-10-10       Impact factor: 4.335

3.  Effectiveness of combined high-dosed trospium and solifenacin depending on severity of OAB symptoms in elderly men and women under cyclic therapy.

Authors:  Kirill Kosilov; Sergey Loparev; Marina Iwanowskaya; Liliya Kosilova
Journal:  Cent European J Urol       Date:  2014-04-17

4.  Ketamine-Induced Apoptosis in Normal Human Urothelial Cells: A Direct, N-Methyl-d-Aspartate Receptor-Independent Pathway Characterized by Mitochondrial Stress.

Authors:  Simon C Baker; Saqib Shabir; Nikolaos T Georgopoulos; Jennifer Southgate
Journal:  Am J Pathol       Date:  2016-03-18       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.